General Information
Get notified when Silk Road Medical, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Silk Road Medical, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About Silk Road Medical, Inc.
Taxonomy: Medical Device, TransCarotid Artery Revascularization, Stroke Prevention, Vascular Disease, Neuroprotection, Endovascular Techniques, Carotid Artery Disease, Surgical Innovation, Clinical Trial, Minimally Invasive Surgery, Vascular Specialists, Arterial Disease, Sunnyvale, California, ENROUTE Neuroprotection System, TCAR Procedure
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 18 Oct 2022 | |
| Post-IPO Debt | •••••• | 1 | •••• •••• | 31 May 2022 |
| Debt Financing | •••••• | 1 |
|
01 Jan 2020 |
| Series C | •••••• | 5 |
|
18 Jul 2017 |
| Private Equity Round | •••••• | 3 |
|
20 Oct 2015 |
FAQ About Silk Road Medical, Inc.
We're actively collecting intelligence on Silk Road Medical, Inc..
Track Silk Road Medical, Inc. to get notifiedDon't just browse. Track.
Signal Tracker monitors Silk Road Medical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.